VASOPHARM
vasopharm is a biopharmaceutical company dedicated to the discovery and development of novel therapeutics for the treatment of cerebro- and cardiovascular diseases and their consequences. In this area, the company is focused on the development of therapeutics influencing the bioavailability of nitric oxide (NO), a cellular signalling molecule involved in many physiological and pathological processes. vasopharm’s drug candidate VAS203 is an allosteric NO synthase inhibitor and represents a completely new class of modulators of nitric oxide synthase (NOS) enzymes. It rapidly lowers excessive NO production in cerebral vessels and tissues, thereby preventing life-threatening increases in intracranial pressure and associated inflammatory processes following traumatic brain injury.
VASOPHARM
Social Links:
Industry:
Biotechnology Medical Therapeutics
Founded:
1998-07-01
Address:
Würzburg, Bayern, Germany
Country:
Germany
Website Url:
http://www.vasopharm.com
Total Employee:
1+
Status:
Active
Contact:
49 931 35 90 99 0
Email Addresses:
[email protected]
Total Funding:
63.23 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon Apache Euro Google Maps Google Maps API Apache 2.4 Vimeo
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Rington Holdings
Rington Holdings investment in Private Equity Round - Vasopharm
Hanseatic Asset Management
Hanseatic Asset Management investment in Private Equity Round - Vasopharm
Bayern Kapital
Bayern Kapital investment in Private Equity Round - Vasopharm
EF Investments
EF Investments investment in Private Equity Round - Vasopharm
HeidelbergCapital Private Equity
HeidelbergCapital Private Equity investment in Private Equity Round - Vasopharm
Future Capital Development Fund
Future Capital Development Fund investment in Private Equity Round - Vasopharm
Entrepreneurs Fund
Entrepreneurs Fund investment in Series G - Vasopharm
Hanseatic Asset Management
Hanseatic Asset Management investment in Series G - Vasopharm
Bayern Kapital
Bayern Kapital investment in Series G - Vasopharm
Fort Rock Capital
Fort Rock Capital investment in Series G - Vasopharm
Official Site Inspections
http://www.vasopharm.com Semrush global rank: 7.23 M Semrush visits lastest month: 550
- Host name: 84.38.79.51
- IP address: 84.38.79.51
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
